The over-expression of ADAM10 in mouse models has been shown to halt Aβ production and subsequent aggregation [8], while the downregulation of ADAM10—through increased levels of its inhibitor, SFRP1 protein—anticipated the appearance of Alzheimer changes in an AD-like mouse model [9]. This evidence concerns the gene ADAM10 and Alzheimer disease.